SANRX PHARMACEUTICALS INC has a total of 15 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are SPROUT PHARMACEUTICALS INC, AWD PHARMA GMBH & CO KG and TAKEDA PHARMACEUTICALS NORTH A.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | India | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Moheno Phillip | 12 |
#2 | Pfleiderer Wolfgang | 7 |
#3 | Fuchs Dietmar | 4 |
#4 | Dipasquale Antonio | 3 |
#5 | Phillip Moheno | 2 |
#6 | Wolfgang Pfleiderer | 2 |
#7 | Rheingold Arnold | 2 |
#8 | Antonio Dipasquale | 1 |
#9 | Arnold Rheingold | 1 |
#10 | Dietmar Fuchs | 1 |
Publication | Filing date | Title |
---|---|---|
US2016015711A1 | CALCIUM PTERIN-6-CARBOXYLATE (CaPTERIN-6-COOH) AS A NOVEL IMMUNO-THERAPEUTIC | |
US2015010509A1 | Calcium folate (cafolate) and therapeutic methods based thereon | |
WO2013112765A1 | Effect of orally administered dipterinyl calcium pentahydrate (dcp) on oral glucose tolerance in dio mice | |
WO2009092050A2 | Pterin based therapies for inflammatory conditions | |
CN101663308A | Dipterinyl calcium pentahydrate (dcp) and therapeutic methods based thereon |